Spotlight on brexpiprazole and its potential in the treatment of schizophrenia and as adjunctive therapy for the treatment of major depression
Dawn Bruijnzeel, Rajiv Tandon Department of Psychiatry, University of Florida College of Medicine, Gainesville, FL, USA Abstract: Antipsychotic agents, utilized for the treatment of a range of psychiatric disorders, differ substantially in terms of their pharmacology and adverse effect profiles. I...
Main Authors: | Bruijnzeel D, Tandon R |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-05-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/spotlight-on-brexpiprazole-and-its-potential-in-the-treatment-of-schiz-peer-reviewed-article-DDDT |
Similar Items
-
Clinical role of brexpiprazole in depression and schizophrenia
by: Parikh NB, et al.
Published: (2017-03-01) -
Post‐hoc analysis investigating the safety and efficacy of brexpiprazole in Japanese patients with schizophrenia who were switched from other antipsychotics in a long‐term study (Secondary Publication)
by: Jun Ishigooka, et al.
Published: (2020-06-01) -
Brexpiprazole in patients with schizophrenia with or without substance use disorder: an observational study
by: Ginevra Lombardozzi, et al.
Published: (2023-12-01) -
Continuation rate for asenapine and brexpiprazole treatment in patients with schizophrenia
by: Yuichi Inoue, et al.
Published: (2021-05-01) -
Clozapine-Treatment-Resistant Schizophrenia Successfully Managed with Brexpiprazole Combination Therapy: Two Case Reports
by: L. Orsolini, et al.
Published: (2022-06-01)